
Formosa Laboratories Inc
TWSE:4746

Operating Margin
Formosa Laboratories Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
TW |
![]() |
Formosa Laboratories Inc
TWSE:4746
|
8.9B TWD |
15%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
793.6B USD |
38%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
393.8B USD |
26%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.3T DKK |
48%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
246.5B CHF |
32%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
235.8B USD |
36%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
180B GBP |
23%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
200.9B CHF |
32%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
166.1B USD |
11%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
148.9B USD |
25%
|
Formosa Laboratories Inc
Glance View
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Formosa Laboratories Inc's most recent financial statements, the company has Operating Margin of 15.3%.